Clinical Epigenetics | Home page

Editors-in-Chief

Lucia Altucci,Universitdegli Studi della Campania, ItalyMarianne Rots,University Medical Center Groningen, Netherlands

Encompassing the broad spectrum of epigenetics research frombasicresearch to innovations in therapeutic treatments,Clinical Epigeneticsis a top tier, open access journal devoted to the study of epigenetic principles and mechanisms as applied to human development,disease, diagnosis and treatment. The journal particularly welcomes submissions involving clinical trials,translational research,new and innovative methodologies and model organisms providing mechanistic insights. The journal is divided into the following sections:

For more information on the section aims and scope visit our sectioninformation page. If you are unclear which section would be best suited to your submission, we invite you to submit a pre-submission inquiry by selecting the Contact Us option here.

Manuscripts focusing on differential RNA expression levels (coding or non-coding) or on RNA modifications cannot be considered for publication in Clinical Epigenetics since these aspects are not part of epigenetics per se.

In general, non-coding RNAs affect their target genes at the RNA level, which classifies these molecules as post-transcriptional gene expression regulators. The chromatin effects induced by some ncRNA do not yet justify this, to be included as a general mechanism of action of non-coding RNAs. Similarly, although modifications of RNA molecules resemble modifications of DNA or histone proteins, so do post-translational modifications of non-chromatin proteins. As such, RNA modifications are a novel class of markers, but they are not different from general posttranslational protein modifications (which also are not considered part of epigenetics).

For manuscripts on non-coding RNAs or RNA modifications to be considered for publication in Clinical Epigenetics, the authors must provide at least one of the following:

Manuscripts reporting on straightforward bioinformatic analyses of publicly accessible databases only, cannot be considered for publication in Clinical Epigenetics, unless the manuscript presents:

In October 2011, Clinical Epigenetics became a fully open access journal and is now published as part of BioMed Central's portfolio of journals. To view the journal's content prior to this transition, please see SpringerLink.

Continued here:
Clinical Epigenetics | Home page